Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate efficacy and safety of Omacor (omega-3-acid ethyl
esters) in patients with recurrent, symptomatic atrial fibrillation.